Figure 5

Correlation between MDM2 and p16. MDM2-positive rate tended to be higher in the p16-negative group than in the p16-positive group in the overall group (P = 0.021) and in cStageIII patients (P = 0.086). This was not seen in cStageI and cStageII cases.